Goñi Fernando, Mathiason Candace K, Yim Lucia, Wong Kinlung, Hayes-Klug Jeanette, Nalls Amy, Peyser Daniel, Estevez Veronica, Denkers Nathaniel, Xu Jinfeng, Osborn David A, Miller Karl V, Warren Robert J, Brown David R, Chabalgoity Jose A, Hoover Edward A, Wisniewski Thomas
Department of Neurology, New York University School of Medicine, 550 First Avenue, New York, NY 10016, United States.
College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, United States.
Vaccine. 2015 Jan 29;33(5):726-33. doi: 10.1016/j.vaccine.2014.11.035. Epub 2014 Dec 21.
Prion disease is a unique category of illness, affecting both animals and humans, in which the underlying pathogenesis is related to a conformational change of a normal, self-protein called PrP(C) (C for cellular) to a pathological and infectious conformer known as PrP(Sc) (Sc for scrapie). Bovine spongiform encephalopathy (BSE), a prion disease believed to have arisen from feeding cattle with prion contaminated meat and bone meal products, crossed the species barrier to infect humans. Chronic wasting disease (CWD) infects large numbers of deer and elk, with the potential to infect humans. Currently no prionosis has an effective treatment. Previously, we have demonstrated we could prevent transmission of prions in a proportion of susceptible mice with a mucosal vaccine. In the current study, white-tailed deer were orally inoculated with attenuated Salmonella expressing PrP, while control deer were orally inoculated with vehicle attenuated Salmonella. Once a mucosal response was established, the vaccinated animals were boosted orally and locally by application of polymerized recombinant PrP onto the tonsils and rectal mucosa. The vaccinated and control animals were then challenged orally with CWD-infected brain homogenate. Three years post CWD oral challenge all control deer developed clinical CWD (median survival 602 days), while among the vaccinated there was a significant prolongation of the incubation period (median survival 909 days; p=0.012 by Weibull regression analysis) and one deer has remained CWD free both clinically and by RAMALT and tonsil biopsies. This negative vaccinate has the highest titers of IgA in saliva and systemic IgG against PrP. Western blots showed that immunoglobulins from this vaccinate react to PrP(CWD). We document the first partially successful vaccination for a prion disease in a species naturally at risk.
朊病毒病是一类独特的疾病,可感染动物和人类,其潜在发病机制与一种名为PrP(C)(C代表细胞型)的正常自身蛋白构象转变为一种病理性且具有传染性的构象体PrP(Sc)(Sc代表羊瘙痒病型)有关。牛海绵状脑病(BSE)是一种朊病毒病,据信是由于用受朊病毒污染的肉骨粉产品喂养牛而引发的,它跨越了物种屏障感染人类。慢性消耗病(CWD)感染大量鹿和麋鹿,有可能感染人类。目前尚无针对朊病毒病的有效治疗方法。此前,我们已证明可以通过黏膜疫苗在一定比例的易感小鼠中预防朊病毒传播。在当前研究中,给白尾鹿口服接种表达PrP的减毒沙门氏菌,而对照鹿口服接种载体减毒沙门氏菌。一旦建立黏膜反应,就通过在扁桃体和直肠黏膜上涂抹聚合重组PrP对已接种疫苗的动物进行口服和局部加强免疫。然后给已接种疫苗和对照的动物口服接种CWD感染的脑匀浆进行攻毒。在CWD口服攻毒三年后,所有对照鹿都出现了临床CWD(中位生存期602天),而在已接种疫苗的鹿中,潜伏期显著延长(中位生存期909天;通过威布尔回归分析,p = 0.012),并且有一只鹿在临床、RAMALT和扁桃体活检方面均未出现CWD。这种阴性疫苗接种在唾液中具有最高滴度的抗PrP IgA和全身性IgG。蛋白质印迹显示,来自这种疫苗接种的免疫球蛋白与PrP(CWD)发生反应。我们记录了在一个自然处于风险的物种中首次对朊病毒病进行的部分成功疫苗接种。